The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study

被引:9
作者
Chayama, Koharu Loulou [1 ,2 ]
Valleriani, Jenna [1 ,2 ]
Ng, Cara [1 ]
Haines-Saah, Rebecca [3 ]
Capler, Rielle [1 ,2 ]
Milloy, M. -J. [1 ,2 ]
Small, Will [1 ,4 ]
McNeil, Ryan [1 ,5 ,6 ]
机构
[1] British Columbia Ctr Subst Use, Vancouver, BC, Canada
[2] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada
[3] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada
[4] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada
[5] Yale Sch Med, Dept Internal Med, New Haven, CT USA
[6] Yale Sch Med, Program Addict Med, New Haven, CT USA
基金
美国国家卫生研究院;
关键词
cannabis; drug use; pain; HIV;
D O I
10.1111/dar.13294
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction People living with HIV who use drugs commonly experience chronic pain and often use illicit opioids to manage pain. Recent research suggests people living with HIV use cannabis for pain relief, including as an adjunct to opioids. This underscores the need to better understand how people living with HIV who use drugs use cannabis for pain management, particularly as cannabis markets are undergoing changes due to cannabis legalisation. Methods From September 2018 to April 2019, we conducted in-depth interviews with 25 people living with HIV who use drugs in Vancouver, Canada to examine experiences using cannabis to manage pain. Interviews were audio-recorded, transcribed and coded. Themes were identified using inductive and deductive approaches. Results Most participants reported that using cannabis for pain management helped improve daily functioning. Some participants turned to cannabis as a supplement or periodic alternative to prescription and illicit drugs (e.g. benzodiazepines, opioids) used to manage pain and related symptoms. Nonetheless, participants' access to legal cannabis was limited and most continued to obtain cannabis from illicit sources, which provided access to cannabis that was free or deemed to be affordable. Discussion and Conclusions Cannabis use may lead to reduced use of prescription and illicit drugs for pain management among some people living with HIV who use drugs. Our findings add to growing calls for additional research on the role of cannabis in pain management and harm reduction, and suggest the need for concrete efforts to ensure equitable access to cannabis.
引用
收藏
页码:1325 / 1333
页数:9
相关论文
共 55 条
  • [1] Cannabis in painful HIV-associated sensory neuropathy - A randomized placebo-controlled trial
    Abrams, D. I.
    Jay, C. A.
    Shade, S. B.
    Vizoso, H.
    Reda, H.
    Press, S.
    Kelly, M. E.
    Rowbotham, M. C.
    Petersen, K. L.
    [J]. NEUROLOGY, 2007, 68 (07) : 515 - 521
  • [2] Achenbach J., 2019, Washington Post
  • [3] Patterns in Outpatient Benzodiazepine Prescribing in the United States
    Agarwal, Sumit D.
    Landon, Bruce E.
    [J]. JAMA NETWORK OPEN, 2019, 2 (01) : e187399
  • [4] [Anonymous], 2016, UND NEW ACC CANN MED
  • [5] Risk Factors and Symptoms Associated With Pain in HIV-Infected Adults
    Aouizerat, Bradley E.
    Miaskowski, Christine A.
    Gay, Caryl
    Portillo, Carmen J.
    Coggins, Traci
    Davis, Harvey
    Pullinger, Clive R.
    Lee, Kathryn A.
    [J]. JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2010, 21 (02): : 125 - 133
  • [6] "Chasing the pain relief, not the high": Experiences managing pain after opioid reductions among patients with HIV and a history of substance use
    Behar, Emily
    Bagnulo, Rita
    Knight, Kelly
    Santos, Glenn-Milo
    Coffin, Phillip O.
    [J]. PLOS ONE, 2020, 15 (03):
  • [7] Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States
    Bing, EG
    Burnam, A
    Longshore, D
    Fleishman, JA
    Sherbourne, CD
    London, AS
    Turner, BJ
    Eggan, F
    Beckman, R
    Vitiello, B
    Morton, SC
    Orlando, M
    Bozzette, SA
    Ortiz-Barron, L
    Shapiro, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (08) : 721 - 728
  • [8] Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study
    Bottorff, Joan L.
    Bissell, Laura J. L.
    Balneaves, Lynda G.
    Oliffe, John L.
    Capler, N. Rielle
    Buxton, Jane
    [J]. HARM REDUCTION JOURNAL, 2013, 10
  • [9] Transitions in income generation among marginalized people who use drugs: A qualitative study on recycling and vulnerability to violence
    Boyd, Jade
    Richardson, Lindsey
    Anderson, Solanna
    Kerr, Thomas
    Small, Will
    McNeil, Ryan
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2018, 59 : 36 - 43
  • [10] Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: Implications and management for clinical practice
    Bruce, RD
    Altice, FL
    Gourevitch, MA
    Friedland, GH
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (05) : 563 - 572